EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Multi‐Center Evaluation of Opioid Administration or Prescription in Pediatric Oncology Patients Using the OMOP CDM

Yuqing Feng iD, Martin Yi, Catherine C Aftandilian, Melissa P Beauchemin iD, Christine Cunningham iD, David DeStephano, Rhea K Khurana iD, Emily Larimer, Jennifer Oberg iD, Benjamin L May, Keith Morse, Karthik Natarajan iD und 6 weitere

Cancer Medicine · 2026-10 · 15 (10)

DOI: 10.1002/cam4.72310 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 28.09.2026. Verfasst von Yuqing Feng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Analgesics, Opioid, Cancer Pain, Neoplasms, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Opioid use in pediatric oncology is poorly characterized. The primary objective was to describe opioid administration or prescription patterns in pediatric oncology patients.

Methods

In this multi‐center retrospective study conducted across three sites, we included patients aged 0–19 years with a malignant neoplastic disease who received their first chemotherapy between January 2019 and March 2024. Data were extracted from each site's Observational Medical Outcomes Partnership Common Data Model. We described patient characteristics based on: (1) first opioid administration or prescription, overall and for each specific opioid; and (2) all opioid administrations or prescriptions, overall and for each specific opioid. We also evaluated variability in opioid and naloxone use.

Results

Of 2903 pediatric patients with cancer, 2707 (93.2%) were administered or prescribed at least one opioid. Among these patients, fentanyl was the most common (92.4%), followed by morphine (68.7%), hydromorphone (55.3%), and oxycodone (38.6%). Across centers, the proportion of patients receiving fentanyl ranged from 90.9% to 94.9%, morphine from 34.0% to 89.2%, oxycodone from 0.9% to 76.1%, and naloxone from 2.4% to 29.5%. Overall, 10.9% were administered or prescribed naloxone, but among 169 methadone patients, 43.5% were administered or prescribed it. Of the 153,849 total opioid administrations or prescriptions, 22.4% occurred more than 12 months after initiating chemotherapy.

Conclusions

Among pediatric patients with cancer who receive chemotherapy, 93.2% were administered or prescribed at least one opioid; fentanyl was the most common. There was heterogeneity in opioid choice and naloxone use across sites. These findings lay preliminary groundwork for understanding opioid use patterns and identifying potential areas for practice improvement in pediatric oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidCancer PainNeoplasmsPractice Patterns, Physicians'AdolescentChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleYoung AdultDrug PrescriptionsMorphineRetrospective Studies

Stichwörter der Autor:innen

OMOP common data modeloncologyopioidpediatric

Substanzen

Analgesics, OpioidMorphine

Autor:innen und Institutionen

  • Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.
  • Columbia University School of Nursing/Herbert Irving Cancer Center, New York, New York, USA.
  • Ben Towne Center for Childhood Cancer and Blood Disorders Research, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
  • Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
  • Stanford Center for Biomedical Informatics Research, Stanford University, Palo Alto, California, USA.

ORCID-Profile: Yuqing Feng, Melissa P Beauchemin, Christine Cunningham, Rhea K Khurana, Jennifer Oberg, Karthik Natarajan, David Noyd, Victoria Soucek, Adam Yan, Lin Lawrence Guo, Lillian Sung

Zitieren

APA

Feng, Y., Yi, M., Aftandilian, C. C., Beauchemin, M. P., Cunningham, C., DeStephano, D., Khurana, R. K., Larimer, E., Oberg, J., May, B. L., Morse, K., Natarajan, K., Noyd, D., Soucek, V., Chen, Y., Yan, A., Guo, L. L., & Sung, L. (2026). Multi‐Center Evaluation of Opioid Administration or Prescription in Pediatric Oncology Patients Using the OMOP CDM. Cancer Medicine, 15(10). https://doi.org/10.1002/cam4.72310

Vancouver

Feng Y, Yi M, Aftandilian CC, Beauchemin MP, Cunningham C, DeStephano D, et al. Multi‐Center Evaluation of Opioid Administration or Prescription in Pediatric Oncology Patients Using the OMOP CDM. Cancer Medicine. 2026;15(10). doi:10.1002/cam4.72310

BibTeX
@article{Feng2026,
  author = {Feng, Yuqing and Yi, Martin and Aftandilian, Catherine C and Beauchemin, Melissa P and Cunningham, Christine and DeStephano, David and Khurana, Rhea K and Larimer, Emily and Oberg, Jennifer and May, Benjamin L and Morse, Keith and Natarajan, Karthik and Noyd, David and Soucek, Victoria and Chen, Yujie and Yan, Adam and Guo, Lin Lawrence and Sung, Lillian},
  title = {Multi‐Center Evaluation of Opioid Administration or Prescription in Pediatric Oncology Patients Using the OMOP CDM},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {10},
  doi = {10.1002/cam4.72310}
}
Kostenlos starten →